Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 12.93 B8.57 B28.25 B10.24 B 59.97 B Research & development ———— — Operating income 0-228.7 M-272.74 M-685.34 M -1.19 B Non-Operating Income, Total 90.28 M-124.23 M957 K158 K -32.84 M Interest expense, net of interest capitalized 14.07 M14.24 M14.41 M16.52 M 59.25 M Non-Operating Income, excl. Interest Expenses 75.53 M-139.39 M-14.41 M-16.52 M -94.79 M Unusual income/expense 672 K918 K957 K158 K 2.71 M Pretax income 042.16 M545.2 M-858.04 M -270.68 M Equity in earnings ———— — Taxes 011.47 M40.15 M-80.94 M -29.33 M Non-controlling/minority interest -185.49 M16.19 M—— — After tax other income/expense ———— — Net income before discontinued operations 030.69 M505.06 M-777.1 M -241.35 M Discontinued operations ———— — Net income 030.69 M505.06 M-777.1 M -241.35 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders -295.43 M30.69 M223.16 M-180.27 M -221.86 M Basic earnings per share (Basic EPS) -0.80.11.19-1.02 -0.53 Diluted earnings per share (Diluted EPS) -0.840.081.01-0.86 -0.61 Average basic shares outstanding —135.53 M174.71 M159.2 M — Diluted shares outstanding -593.18 M135.53 M221.46 M366.48 M 366.48 M EBITDA 12.61 M-221.24 M-265.34 M-407.25 M -881.22 M EBIT 0-228.7 M-272.74 M-685.34 M -1.19 B Cost of revenue ———— — Other cost of goods sold ———— — Depreciation & amortization (cash flow) 12.61 M7.46 M7.4 M6.6 M 34.07 M